Vitamin E modulation of C-reactive protein in smokers with acute coronary syndromes

Free Radical Biology and Medicine

Volumn 36, Issue 8, 2004, Pages 959-965

  Murphy, Ross T ^a,c   Foley, J Brendan ^a   Tome, Marie Teresa ^a   Mulvihill, Niall T ^a   Murphy, Anne ^b   McCarroll, Nuala ^a   Crean, Peter ^a   Walsh, Micheal J ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b Dublin Molecular Medicine Centre   (Ireland)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Acute coronary syndromes; C reactive protein; Free radicals; Inflammation; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; INTERLEUKIN 6; PLACEBO;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR MALFORMATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INFLAMMATION; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; C-REACTIVE PROTEIN; CELL ADHESION MOLECULES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOUBLE-BLIND METHOD; E-SELECTIN; FEMALE; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; P-SELECTIN; PLACEBOS; PROGNOSIS; SMOKING; TIME FACTORS; UP-REGULATION; VITAMIN E;

EID: 1842579215     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2004.01.018     Document Type: Article

References (49)

1. Ross R. Atherosclerosis: an inflammatory disease (Review). N. Engl. J. Med. 340:1999;215-221.
2. Braunwald E. Unstable angina; an etiological approach to management. Circulation. 98:1998;2219-2222.
3. Haverkate F., Thompson S.G., Pyke S.D.M., Gallimore R., Pepys M. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 349:1999;462-469.
4. Blake G., Ridker P.M. C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular events. Arterioscler. Thromb. Vasc. Biol. 22:2002;1512-1513.
5. Lenderink T., Boersma E., Heeschen C., Vahanian A., de Boer M.J., Umans V., Hamm C.W., Simmons M.L. Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA. Eur. Heart. J. 24:2003;77-85.
6. Mulvihill N., Foley J.B., Murphy R.T., Crean P., Walsh M. Evidence of prolonged inflammation in unstable angina and non-Q wave myocardial infarction. J. Am. Coll. Cardiol. 36:2000;1210-1216.
7. Mulvihill N., Foley J.B., Ghaisis N., Murphy R., Crean P., Walsh M. Early temporal expression of soluble cell adhesion molecules in subendocardial myocardial infarction and unstable angina. Am. J. Cardiol. 83:1999;1265-1268.
8. Erren M., Reinecke H., Junker R., Fobker M., Schulte H., Schurek J.O., Kropf J., Kerber S., Breithhardt G., Assmann G., Cullen P. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler. Thromb. Vasc. Biol. 19:1999;2355-2363.
9. Ikonomidis I., Andreotti F., Economou E., Stefanadis C., Toutouzas P., Nihoyannopoulos P. Increased pro-inflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation. 100:1999;793-798.
10. Ridker P.M., Rifai N., Pfeffer M., Sacks F., Braunwald E., for the CARE Investigators Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation. 97:1998;839-844.
11. Stephens N.G., Parsons A., Schofield P.M., Kelly F., Cheesman K., Mitchinson M.J., Brown M.J. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 347:1996;781-786.
12. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators Vitamin E supplementation and cardiovascular events in high-risk patients. N. Engl. J. Med. 342:2000;154-160.
13. Boaz M., Smetana S., Weinstein T., Matas Z., Gafter U., Iaina A., Knecht A., Weissgarten Y., Brunner D., Fainaru M., Green M.S. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet. 356:2000;1213-1218.
14. Hodis H.N., Mack W.J., LaBree L., Mahrer P.R., Sevabian A., Liu C., Hwang J., Selzer R.H., Azen S.P. Alpha-tocopherol supplementation in healthy individuals reduces low-density oxidation but not atherosclerosis. Circulation. 106:2002;1453-1459.
15. Deveraj S., Jialal I. The effects of alpha-tocopherol on critical cells in atherogenesis. Curr. Opin. Lipidol. 9:1998;11-15.
16. Devaraj S., Jialal I. Alpha-tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radic. Biol. Med. 29:2000;790-792.
17. Yousoulis D., Antoniades C., Toutouza M., Tentolouris C., Marianou K., Goumas G., Trikas A., Toutouzas C., Stefanadis C., Toutouzas P. Vitamin C and E administration in smokers: effect on endothelial function and serum levels of soluble intercellular adhesion mlecule-1 and soluble vascular cell adhesion molecule, and lipid peroxides. J. Am. Coll. Cardiol. 30(2, Suppl.):2002;213A.
18. Thurnham D.I., Davies J.A., Crump B.J., Situnayake R.D., Davis M. The use of different lipids to express serum tocopherol: lipid ratios for measuring vitamin E status. Ann. Clin. Biochem. 23:1986;514-520.
19. Ferreiros E.R., Boissonnet C.P., Pizarro R., Merletti P.F., Corrado G., Cagide A., Bazzino O.O. Independent prognostic value of elevated C-reactive protein in unstable angina. Circulation. 100:1999;1958-1963.
20. Theroux P., Liddon R.M. Unstable angina; pathogenesis, diagnosis and treatment. Curr. Prob. Cardiol. 18:1993;157-231.
21. Cermak J., Key N.S., Bach R.R., Balla J., Jacob H.S., Vercellotti G.M. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 82:1993;513-520.
22. Jialal I., Deveraj S. Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker. Am. J. Clin. Pathol. 116(Suppl.):2001;S108-S115.
23. Magyar M.T., Szikszai Z., Balla J., Valikovics A., Kappelmayer J., Imre S., Balla G., Jeney V., Csiba L., Bereczki D. Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers. Stroke. 34:2003;58-63.
24. Wallenfeldt K., Hulthe J., Bokemark L., Wikstrand J., Fagerberg B. Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking in 58-year-old men. J. Intern. Med. 250:2001;492-501.
25. Cusack M., Marber M.S., Odemuyiwa P. Does myocardial necrosis contribute to the inflammatory response in unstable angina (abstract)? Eur. J. Heart. 21:2000;A245.
26. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., Willett W.C. Vitamin E consumption and the risk of coronary disease in men. N. Engl. J. Med. 328:1993;1450-1456.
27. Stampfer M.J., Hennekens C.H., Manson J.E., Colditz G.A., Rosner B., Willett W. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 328:1993;1444-1449.
28. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witzum J.L. Beyond cholesterol: modification of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
29. Steinberg D. Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis? Curr. Opin. Lipidol. 11:2000;603-607.
30. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 360:2002;23-33.
31. GISSI-Prevenzione investigators Dietary supplementation with N-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 354:1999;447-455.
32. Ness A., Smith G.D. Mortality in the CHAOS trial: Cambridge Heart Antioxidant Study. Lancet. 353:1999;1017-1018.
33. Faruqi R., Motte C., Dicorleto P.E. Alpha-tocopherol inhibits agonist induced monocyte cell adhesion to cultured human endothelial cells. J. Clin. Invest. 94:1994;592-600.
34. Webel D.M., Mahan D.C., Jonson R.W., Baker D.H. Pretreatment of young pigs with vitamin E attenuates the elevation on plasma IL-6 and cortisol by a challenge dose of lipopolysaccharide. J. Nutr. 128:1998;1657-1660.
35. Deveraj S., Li D., Jialial I. The effect of AT supplementation on monocyte function decreased lipid oxidation, Il-β secretion and monocyte adhesion to endothelium. J. Clin. Invest. 98:1996;756-763.
36. Erl W., Weber C., Wardemann C., Weber P.C. AT succinate inhibits monocytic cell adhesion to endothelial cells by suppressing NFκB mobilization. Am. J. Physiol. 273:1997;H634-H640.
37. Wu D., Koga T., Martin K.R., Meydani M. Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes. Atherosclerosis. 147:1999;297-307.
38. Azzi A., Boscoboinik D., Marilley D., Ozer N.K., Stauble B., Tasinato A. Vitamin E: a sensor and information transducer of the cell oxidation state. Am. J. Clin. Nutr. 62(Suppl.):1995;1337-1346.
39. Ricciarelli R., Tasinato A., Clement S., Ozer N.K., Boscoboinik D., Azzi A. Alpha-tocopherol specifically inactivates cellular protein kinase C-α by changing its phophorylation state. Biochem. J. 334:1998;243-249.
40. Venugopal S.K., Deveraj S., Yang T., Jialal I. Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycaemic conditions via inhibition of protein kinase C-alpha. Diabetes. 51:2002;3049-3054.
41. Islam K.N., Devaraj S., Jialal I. Alpha-tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells. Circulation. 98:1998;2255-2261.
42. Suzuki Y.J., Packer L. Inhibition of NFκB activation by vitamin E derivatives. Biochem. Biophys. Res. Commun. 193:1993;277-283.
43. Patrignani P., Panara M.R., Tacconelli S., Seta F., Bucciarelli T., Ciabottoni G., Alessandrini P., Mezzetti A., Santini G., Sciulli M.G., Cipollone F., Davi G., Gallina P., Pon G.B., Patrono C. Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. Circulation. 102:2000;539-545.
44. Leppala J.M., Virtamo J., Fogelholm R., Albanes D., Taylor P.R., Heinonen O.P. Vitamin E and beta carotene supplementation in high risk for stroke: a subgroup analysis of the alpha-tocopherol, beta carotene cancer prevention study. Arch. Neurol. 57:2000;1503-1509.
45. Heitzer T., Yla-Herrttuala S., Wild E., Luoma J., Drexler H. Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking, or both. J. Am. Coll. Cardiol. 33:1999;499-505.
46. de Waart F.G., Kok F.J., Smilde T.J., Hijmans A., Wollerheim H., Stalenhof A.F.H. Effect of glutathione S-transferase M1 genotype on progression of atherosclerosis in lifelong male smokers. Atherosclerosis. 158:2002;227-231.
47. Riemersma R.A., Wood D.A., Macintyre C.C., Elton R., Gey K.F., Oliver M.F. Low plasma vitamins E and C: increased risk of angina on Scottish men. Ann. NY Acad. Sci. 570:1989;291-295.
48. Fang J.C., Kinlay S., Beltrame J., Hikiti H., Wainstein M., Behrendt D., Suh J., Frei B., Modge G.H., Selwyn A.P., Ganz P. Effects of vitamins C and E on progression of transplant associated atherosclerosis: a randomised trial. Lancet. 359:2002;1108-1134.
49. Saldeen T., Li D., Mehta J.L. Differential effects of α- and γ-tocopherol on LDL oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. J. Am. Coll. Cardiol. 34:1999;1208-1215.